APO Research
Talk to an analyst

APO RESEARCH · REPORT

L-(+)-Ergothioneine

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol. Its molecular structure contains a trimethylated histidine backbone and a sulfur substituted imidazole ring, forming an amino acid betaine with a permanent zwitterionic character. The molecule exists in equilibrium between thiol and thione tautomers. At physiological pH the thione form predominates, which substantially limits spontaneous oxidation and gives ergothioneine greater chemical stability than many conventional low molecular weight thiols. This thione chemistry also permits redox reactions and transition metal coordination while retaining high aqueous solubility. High purity commercial material is typically supplied as a white crystalline powder. The synthetic material assessed by the European Food Safety Authority specifies chemical purity of at least 99.5 percent by HPLC and positive optical rotation consistent with the naturally occurring L configuration.

Natural ergothioneine biosynthesis occurs in selected fungi and bacteria through histidine derived sulfur incorporation pathways. Mushrooms contain particularly high concentrations, while lower concentrations occur in beans, cereals, animal tissues and other foods through biological uptake and food chain transfer. Humans do not possess a known endogenous biosynthetic pathway for ergothioneine and obtain it from dietary sources. Absorption and tissue retention are strongly associated with the SLC22A4 transporter, commonly termed OCTN1 or the ergothioneine transporter, which mediates intestinal uptake, cellular accumulation and renal reabsorption. Ergothioneine can consequently accumulate in erythrocytes and several tissues despite relatively low dietary concentrations. Its thione dominated chemistry gives the molecule resistance to autoxidation and enables reactions with reactive oxygen and nitrogen species and coordination with selected metal ions. These physicochemical properties underpin its use as a functional ingredient, while its precise physiological roles in humans remain an active area of biochemical research.

Industrial L (+) Ergothioneine is manufactured principally by microbial fermentation, enzyme catalyzed synthesis and chemical synthesis. Commercial fermentation routes use engineered microorganisms carrying ergothioneine biosynthetic enzymes, with current FDA GRAS records documenting production using engineered Escherichia coli strains. Chemical production has also been established commercially and was the manufacturing basis of the synthetic material evaluated by EFSA. Enzyme catalyzed routes convert histidine derived precursors through selective sulfur incorporation reactions and are currently used by commercial ingredient manufacturers. These technologies produce chemically equivalent L ergothioneine when stereochemical configuration, molecular identity, purity and impurity specifications are controlled. Commercial material is used in dietary supplements, foods and beverages, cosmetics and personal care formulations, with food use subject to jurisdiction specific regulatory requirements. The European Union currently lists L ergothioneine as an authorised novel food for specified food categories and food supplements.

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For L-(+)-Ergothioneine, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable l-(+)-ergothioneine performance?

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Market Analysis & Forecast

Global L-(+)-Ergothioneine Market Analysis and Forecast 2026-2032

6 September 2026206 pages

Choose your research edition.

Industry ResearchL-(+)-Ergothioneine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal L-(+)-Ergothioneine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal L-(+)-Ergothioneine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal L-(+)-Ergothioneine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal L-(+)-Ergothioneine Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

According to APO Research, Inc, the global L (+) Ergothioneine market was valued at USD 68.53 million in 2025 and is expected to reach USD 84.17 million in 2026 and USD 191.86 million by 2032, representing a CAGR of 14.72% from 2026 to 2032. Global sales volume is estimated at 25.86 t in 2025 and 33.40 t in 2026, reaching 107.79 t in 2032, equivalent to a volume CAGR of 21.56%. The weighted ex factory net price is estimated at USD 2,650.00 per kg in 2025, USD 2,520.00 per kg in 2026 and USD 1,780.00 per kg in 2032, corresponding to an average annual price decline of 5.63% during 2026 to 2032. Effective manufacturing capacity is estimated at 72.50 t in 2025, 92.01 t in 2026 and 189.97 t in 2032, while utilization increases from 35.67% to 36.30% and 56.74%, respectively. The value expansion therefore comes primarily from higher physical consumption, rising utilization and broader downstream formulation volumes as fermentation productivity and purification economics reduce unit cost.

China is expected to contribute the largest manufacturing increment through GeneIII Biotechnology, Chuanning Biotechnology, Shanghai EGT Synbio, Readline Biotech, SIYOMICRO, Bloomage Biotech, Abiochem and other commercial producers. GeneIII reports monthly L (+) Ergothioneine capacity of 3.00 to 5.00 t, equivalent to 36.00 to 60.00 t on an annualized basis, with product purity reaching 99.99%. This disclosed capacity alone exceeds the audited 2026 global sales volume of 33.40 t and provides a direct physical explanation for the relatively low industry utilization rate. SIYOMICRO has reported stable production scale up in a 100.00 t fermenter, while Readline has commissioned two hundred tonne class shared active ingredient production lines in Zhuhai with commercial scale production of ergothioneine. Chuanning exceeded its 11.00 g/L fermentation titer objective and annual production target in 2025. Bloomage commercially produces MitoEGT through one step biosynthesis, and Shanghai EGT Synbio has established commercial biological production of Dr.Ergo. The current FDA GRAS inventory contains four ergothioneine notices. Blue California, Shanghai EGT Synbio and GeneIII have received FDA no questions letters. Abiochem remains under review.

Fermentation is expected to account for the largest incremental production volume through 2032 as strain productivity, fermentation titer, reactor scale, downstream recovery and crystallization yield improve. Enzymatic synthesis and chemical synthesis remain relevant for selected manufacturing configurations and purity specifications. Dietary supplements are expected to remain the largest application by value, followed by food and beverages and cosmetics and personal care, with pet nutrition representing a smaller commercial application. Regulatory inclusion levels provide a useful physical demand anchor. The European Union permits up to 30.00 mg per day in food supplements for the general population, 25.00 mg per kg in alcohol free beverages and milk based drinks, 40.00 mg per kg in fresh milk products, 200.00 mg per kg in cereal bars and 250.00 mg per kg in chocolate confectionery. At 30.00 mg per day, 1.00 t of L (+) Ergothioneine corresponds to approximately 33.33 million supplement consumption days. At 25.00 mg per kg, 1.00 t can theoretically supply 40,000.00 t of beverage at the permitted maximum inclusion level. These low unit dosages allow large downstream finished product volumes to absorb relatively modest ingredient tonnage, while continued price reductions materially enlarge the addressable formulation base. Commercial demand is recurrent because L (+) Ergothioneine is consumed within finished formulations and replenished with continuing supplement, food, beverage, cosmetic and pet nutrition production.

Read the full market overview

This report presents an overview of global market for L-(+)-Ergothioneine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of L-(+)-Ergothioneine, also provides the sales of main regions and countries. Of the upcoming market potential for L-(+)-Ergothioneine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the L-(+)-Ergothioneine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global L-(+)-Ergothioneine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for L-(+)-Ergothioneine sales, projected growth trends, production technology, application and end-user industry.

L-(+)-Ergothioneine Segment by Company

Bloomage Biotech

Chuanning Biotechnology

Shanghai EGT Synbio

GeneIII Biotechnology

Readline Biotech

SIYOMICRO

Abiochem

Magic Health

Seedling Bio

Focusfreda

Nutri Force

Natural Field

GsynBio

Hechen Bioworkx

Changzhou Kaixing Biotechnology

Spec Chem Industry

Conagen

Mironova Labs

NAGASE

L-(+)-Ergothioneine Segment by Type

Fermentation

Enzymatic Synthesis

Chemical Synthesis

L-(+)-Ergothioneine Segment by Application

Dietary Supplements

Food & Beverages

Cosmetics & Personal Care

Pet Nutrition

L-(+)-Ergothioneine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global L-(+)-Ergothioneine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of L-(+)-Ergothioneine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of L-(+)-Ergothioneine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of L-(+)-Ergothioneine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of L-(+)-Ergothioneine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, L-(+)-Ergothioneine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global L-(+)-Ergothioneine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fermentation Major Manufacturers Table 3. Enzymatic Synthesis Major Manufacturers Table 4. Chemical Synthesis Major Manufacturers Table 5. Global L-(+)-Ergothioneine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Dietary Supplements Major Manufacturers Table 7. Food & Beverages Major Manufacturers Table 8. Cosmetics & Personal Care Major Manufacturers Table 9. Pet Nutrition Major Manufacturers Table 10. L-(+)-Ergothioneine Industry Trends Table 11. L-(+)-Ergothioneine Industry Drivers Table 12. L-(+)-Ergothioneine Industry Opportunities and Challenges Table 13. L-(+)-Ergothioneine Industry Restraints Table 14. Global L-(+)-Ergothioneine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global L-(+)-Ergothioneine Revenue by Region (2021-2026) & (US$ Million) Table 16. Global L-(+)-Ergothioneine Revenue by Region (2027-2032) & (US$ Million) Table 17. Global L-(+)-Ergothioneine Revenue Market Share by Region (2021-2026) Table 18. Global L-(+)-Ergothioneine Revenue Market Share by Region (2027-2032) Table 19. Global L-(+)-Ergothioneine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 20. Global L-(+)-Ergothioneine Sales by Region (2021-2026) & (kg) Table 21. Global L-(+)-Ergothioneine Sales by Region (2027-2032) & (kg) Table 22. Global L-(+)-Ergothioneine Sales Market Share by Region (2021-2026) Table 23. Global L-(+)-Ergothioneine Sales Market Share by Region (2027-2032) Table 24. Global L-(+)-Ergothioneine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global L-(+)-Ergothioneine Revenue Market Share by Manufacturers (2021-2026) Table 26. Global L-(+)-Ergothioneine Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global L-(+)-Ergothioneine Sales Market Share by Manufacturers (2021-2026) Table 28. Global L-(+)-Ergothioneine Sales Price (USD/kg) of Manufacturers (2021-2026) Table 29. Global L-(+)-Ergothioneine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global L-(+)-Ergothioneine Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global L-(+)-Ergothioneine Manufacturers, Product Type & Application Table 32. Global L-(+)-Ergothioneine Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global L-(+)-Ergothioneine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global L-(+)-Ergothioneine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global L-(+)-Ergothioneine Revenue by Type (2021-2026) & (US$ Million) Table 37. Global L-(+)-Ergothioneine Revenue by Type (2027-2032) & (US$ Million) Table 38. Global L-(+)-Ergothioneine Revenue Market Share by Type (2021-2026) Table 39. Global L-(+)-Ergothioneine Revenue Market Share by Type (2027-2032) Table 40. Global L-(+)-Ergothioneine Sales by Type 2021 VS 2025 VS 2032 (kg) Table 41. Global L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 42. Global L-(+)-Ergothioneine Sales by Type (2027-2032) & (kg) Table 43. Global L-(+)-Ergothioneine Sales Market Share by Type (2021-2026) Table 44. Global L-(+)-Ergothioneine Sales Market Share by Type (2027-2032) Table 45. Global L-(+)-Ergothioneine Price by Type (2021-2026) & (USD/kg) Table 46. Global L-(+)-Ergothioneine Price by Type (2027-2032) & (USD/kg) Table 47. Global L-(+)-Ergothioneine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global L-(+)-Ergothioneine Revenue by Application (2021-2026) & (US$ Million) Table 49. Global L-(+)-Ergothioneine Revenue by Application (2027-2032) & (US$ Million) Table 50. Global L-(+)-Ergothioneine Revenue Market Share by Application (2021-2026) Table 51. Global L-(+)-Ergothioneine Revenue Market Share by Application (2027-2032) Table 52. Global L-(+)-Ergothioneine Sales by Application 2021 VS 2025 VS 2032 (kg) Table 53. Global L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 54. Global L-(+)-Ergothioneine Sales by Application (2027-2032) & (kg) Table 55. Global L-(+)-Ergothioneine Sales Market Share by Application (2021-2026) Table 56. Global L-(+)-Ergothioneine Sales Market Share by Application (2027-2032) Table 57. Global L-(+)-Ergothioneine Price by Application (2021-2026) & (USD/kg) Table 58. Global L-(+)-Ergothioneine Price by Application (2027-2032) & (USD/kg) Table 59. Bloomage Biotech Company Information Table 60. Bloomage Biotech Business Overview Table 61. Bloomage Biotech L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 62. Bloomage Biotech L-(+)-Ergothioneine Product Portfolio Table 63. Bloomage Biotech Recent Development Table 64. Chuanning Biotechnology Company Information Table 65. Chuanning Biotechnology Business Overview Table 66. Chuanning Biotechnology L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 67. Chuanning Biotechnology L-(+)-Ergothioneine Product Portfolio Table 68. Chuanning Biotechnology Recent Development Table 69. Shanghai EGT Synbio Company Information Table 70. Shanghai EGT Synbio Business Overview Table 71. Shanghai EGT Synbio L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 72. Shanghai EGT Synbio L-(+)-Ergothioneine Product Portfolio Table 73. Shanghai EGT Synbio Recent Development Table 74. GeneIII Biotechnology Company Information Table 75. GeneIII Biotechnology Business Overview Table 76. GeneIII Biotechnology L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 77. GeneIII Biotechnology L-(+)-Ergothioneine Product Portfolio Table 78. GeneIII Biotechnology Recent Development Table 79. Readline Biotech Company Information Table 80. Readline Biotech Business Overview Table 81. Readline Biotech L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 82. Readline Biotech L-(+)-Ergothioneine Product Portfolio Table 83. Readline Biotech Recent Development Table 84. SIYOMICRO Company Information Table 85. SIYOMICRO Business Overview Table 86. SIYOMICRO L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 87. SIYOMICRO L-(+)-Ergothioneine Product Portfolio Table 88. SIYOMICRO Recent Development Table 89. Abiochem Company Information Table 90. Abiochem Business Overview Table 91. Abiochem L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 92. Abiochem L-(+)-Ergothioneine Product Portfolio Table 93. Abiochem Recent Development Table 94. Magic Health Company Information Table 95. Magic Health Business Overview Table 96. Magic Health L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 97. Magic Health L-(+)-Ergothioneine Product Portfolio Table 98. Magic Health Recent Development Table 99. Seedling Bio Company Information Table 100. Seedling Bio Business Overview Table 101. Seedling Bio L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 102. Seedling Bio L-(+)-Ergothioneine Product Portfolio Table 103. Seedling Bio Recent Development Table 104. Focusfreda Company Information Table 105. Focusfreda Business Overview Table 106. Focusfreda L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 107. Focusfreda L-(+)-Ergothioneine Product Portfolio Table 108. Focusfreda Recent Development Table 109. Nutri Force Company Information Table 110. Nutri Force Business Overview Table 111. Nutri Force L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 112. Nutri Force L-(+)-Ergothioneine Product Portfolio Table 113. Nutri Force Recent Development Table 114. Natural Field Company Information Table 115. Natural Field Business Overview Table 116. Natural Field L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 117. Natural Field L-(+)-Ergothioneine Product Portfolio Table 118. Natural Field Recent Development Table 119. GsynBio Company Information Table 120. GsynBio Business Overview Table 121. GsynBio L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 122. GsynBio L-(+)-Ergothioneine Product Portfolio Table 123. GsynBio Recent Development Table 124. Hechen Bioworkx Company Information Table 125. Hechen Bioworkx Business Overview Table 126. Hechen Bioworkx L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 127. Hechen Bioworkx L-(+)-Ergothioneine Product Portfolio Table 128. Hechen Bioworkx Recent Development Table 129. Changzhou Kaixing Biotechnology Company Information Table 130. Changzhou Kaixing Biotechnology Business Overview Table 131. Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 132. Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Product Portfolio Table 133. Changzhou Kaixing Biotechnology Recent Development Table 134. Spec Chem Industry Company Information Table 135. Spec Chem Industry Business Overview Table 136. Spec Chem Industry L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 137. Spec Chem Industry L-(+)-Ergothioneine Product Portfolio Table 138. Spec Chem Industry Recent Development Table 139. Conagen Company Information Table 140. Conagen Business Overview Table 141. Conagen L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 142. Conagen L-(+)-Ergothioneine Product Portfolio Table 143. Conagen Recent Development Table 144. Mironova Labs Company Information Table 145. Mironova Labs Business Overview Table 146. Mironova Labs L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 147. Mironova Labs L-(+)-Ergothioneine Product Portfolio Table 148. Mironova Labs Recent Development Table 149. NAGASE Company Information Table 150. NAGASE Business Overview Table 151. NAGASE L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 152. NAGASE L-(+)-Ergothioneine Product Portfolio Table 153. NAGASE Recent Development Table 154. North America L-(+)-Ergothioneine Revenue by Type (2021-2026) & (US$ Million) Table 155. North America L-(+)-Ergothioneine Revenue by Type (2027-2032) & (US$ Million) Table 156. North America L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 157. North America L-(+)-Ergothioneine Sales by Type (2027-2032) & (kg) Table 158. North America L-(+)-Ergothioneine Sales Price by Type (2021-2026) & (USD/kg) Table 159. North America L-(+)-Ergothioneine Sales Price by Type (2027-2032) & (USD/kg) Table 160. North America L-(+)-Ergothioneine Revenue by Application (2021-2026) & (US$ Million) Table 161. North America L-(+)-Ergothioneine Revenue by Application (2027-2032) & (US$ Million) Table 162. North America L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 163. North America L-(+)-Ergothioneine Sales by Application (2027-2032) & (kg) Table 164. North America L-(+)-Ergothioneine Sales Price by Application (2021-2026) & (USD/kg) Table 165. North America L-(+)-Ergothioneine Sales Price by Application (2027-2032) & (USD/kg) Table 166. North America L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. North America L-(+)-Ergothioneine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. North America L-(+)-Ergothioneine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. North America L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 170. North America L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 171. North America L-(+)-Ergothioneine Sales by Country (2027-2032) & (kg) Table 172. North America L-(+)-Ergothioneine Sales Price by Country (2021-2026) & (USD/kg) Table 173. North America L-(+)-Ergothioneine Sales Price by Country (2027-2032) & (USD/kg) Table 174. United States L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 175. Canada L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 176. Mexico L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 177. Europe L-(+)-Ergothioneine Revenue by Type (2021-2026) & (US$ Million) Table 178. Europe L-(+)-Ergothioneine Revenue by Type (2027-2032) & (US$ Million) Table 179. Europe L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 180. Europe L-(+)-Ergothioneine Sales by Type (2027-2032) & (kg) Table 181. Europe L-(+)-Ergothioneine Sales Price by Type (2021-2026) & (USD/kg) Table 182. Europe L-(+)-Ergothioneine Sales Price by Type (2027-2032) & (USD/kg) Table 183. Europe L-(+)-Ergothioneine Revenue by Application (2021-2026) & (US$ Million) Table 184. Europe L-(+)-Ergothioneine Revenue by Application (2027-2032) & (US$ Million) Table 185. Europe L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 186. Europe L-(+)-Ergothioneine Sales by Application (2027-2032) & (kg) Table 187. Europe L-(+)-Ergothioneine Sales Price by Application (2021-2026) & (USD/kg) Table 188. Europe L-(+)-Ergothioneine Sales Price by Application (2027-2032) & (USD/kg) Table 189. Europe L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Europe L-(+)-Ergothioneine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Europe L-(+)-Ergothioneine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Europe L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 193. Europe L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 194. Europe L-(+)-Ergothioneine Sales by Country (2027-2032) & (kg) Table 195. Europe L-(+)-Ergothioneine Sales Price by Country (2021-2026) & (USD/kg) Table 196. Europe L-(+)-Ergothioneine Sales Price by Country (2027-2032) & (USD/kg) Table 197. Germany L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 198. France L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 199. U.K. L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 200. Italy L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 201. Russia L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 202. Spain L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 203. Netherlands L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 204. Switzerland L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 205. Sweden L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 206. Poland L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 207. China L-(+)-Ergothioneine Revenue by Type (2021-2026) & (US$ Million) Table 208. China L-(+)-Ergothioneine Revenue by Type (2027-2032) & (US$ Million) Table 209. China L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 210. China L-(+)-Ergothioneine Sales by Type (2027-2032) & (kg) Table 211. China L-(+)-Ergothioneine Sales Price by Type (2021-2026) & (USD/kg) Table 212. China L-(+)-Ergothioneine Sales Price by Type (2027-2032) & (USD/kg) Table 213. China L-(+)-Ergothioneine Revenue by Application (2021-2026) & (US$ Million) Table 214. China L-(+)-Ergothioneine Revenue by Application (2027-2032) & (US$ Million) Table 215. China L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 216. China L-(+)-Ergothioneine Sales by Application (2027-2032) & (kg) Table 217. China L-(+)-Ergothioneine Sales Price by Application (2021-2026) & (USD/kg) Table 218. China L-(+)-Ergothioneine Sales Price by Application (2027-2032) & (USD/kg) Table 219. Asia L-(+)-Ergothioneine Revenue by Type (2021-2026) & (US$ Million) Table 220. Asia L-(+)-Ergothioneine Revenue by Type (2027-2032) & (US$ Million) Table 221. Asia L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 222. Asia L-(+)-Ergothioneine Sales by Type (2027-2032) & (kg) Table 223. Asia L-(+)-Ergothioneine Sales Price by Type (2021-2026) & (USD/kg) Table 224. Asia L-(+)-Ergothioneine Sales Price by Type (2027-2032) & (USD/kg) Table 225. Asia L-(+)-Ergothioneine Revenue by Application (2021-2026) & (US$ Million) Table 226. Asia L-(+)-Ergothioneine Revenue by Application (2027-2032) & (US$ Million) Table 227. Asia L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 228. Asia L-(+)-Ergothioneine Sales by Application (2027-2032) & (kg) Table 229. Asia L-(+)-Ergothioneine Sales Price by Application (2021-2026) & (USD/kg) Table 230. Asia L-(+)-Ergothioneine Sales Price by Application (2027-2032) & (USD/kg) Table 231. Asia L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. Asia L-(+)-Ergothioneine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. Asia L-(+)-Ergothioneine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. Asia L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 235. Asia L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 236. Asia L-(+)-Ergothioneine Sales by Country (2027-2032) & (kg) Table 237. Asia L-(+)-Ergothioneine Sales Price by Country (2021-2026) & (USD/kg) Table 238. Asia L-(+)-Ergothioneine Sales Price by Country (2027-2032) & (USD/kg) Table 239. Japan L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 240. South Korea L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 241. India L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 242. Australia L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 243. Taiwan L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 244. Southeast Asia L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 245. SAMEA L-(+)-Ergothioneine Revenue by Type (2021-2026) & (US$ Million) Table 246. SAMEA L-(+)-Ergothioneine Revenue by Type (2027-2032) & (US$ Million) Table 247. SAMEA L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 248. SAMEA L-(+)-Ergothioneine Sales by Type (2027-2032) & (kg) Table 249. SAMEA L-(+)-Ergothioneine Sales Price by Type (2021-2026) & (USD/kg) Table 250. SAMEA L-(+)-Ergothioneine Sales Price by Type (2027-2032) & (USD/kg) Table 251. SAMEA L-(+)-Ergothioneine Revenue by Application (2021-2026) & (US$ Million) Table 252. SAMEA L-(+)-Ergothioneine Revenue by Application (2027-2032) & (US$ Million) Table 253. SAMEA L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 254. SAMEA L-(+)-Ergothioneine Sales by Application (2027-2032) & (kg) Table 255. SAMEA L-(+)-Ergothioneine Sales Price by Application (2021-2026) & (USD/kg) Table 256. SAMEA L-(+)-Ergothioneine Sales Price by Application (2027-2032) & (USD/kg) Table 257. SAMEA L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 258. SAMEA L-(+)-Ergothioneine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 259. SAMEA L-(+)-Ergothioneine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 260. SAMEA L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 261. SAMEA L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 262. SAMEA L-(+)-Ergothioneine Sales by Country (2027-2032) & (kg) Table 263. SAMEA L-(+)-Ergothioneine Sales Price by Country (2021-2026) & (USD/kg) Table 264. SAMEA L-(+)-Ergothioneine Sales Price by Country (2027-2032) & (USD/kg) Table 265. Brazil L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 266. Argentina L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 267. Chile L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 268. Colombia L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 269. Peru L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 270. Saudi Arabia L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 271. Israel L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 272. UAE L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 273. Turkey L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 274. Iran L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 275. Egypt L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Table 276. Key Raw Materials Table 277. Raw Materials Key Suppliers Table 278. L-(+)-Ergothioneine Distributors List Table 279. L-(+)-Ergothioneine Customers List Table 280. Research Programs/Design for This Report Table 281. Authors List of This Report Table 282. Secondary Sources Table 283. Primary Sources List of Figures Figure 1. L-(+)-Ergothioneine Image Figure 2. Global L-(+)-Ergothioneine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global L-(+)-Ergothioneine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fermentation Image Figure 5. Enzymatic Synthesis Image Figure 6. Chemical Synthesis Image Figure 7. Global L-(+)-Ergothioneine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global L-(+)-Ergothioneine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Dietary Supplements Image Figure 10. Food & Beverages Image Figure 11. Cosmetics & Personal Care Image Figure 12. Pet Nutrition Image Figure 13. Global L-(+)-Ergothioneine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global L-(+)-Ergothioneine Revenue (2021-2032) & (US$ Million) Figure 15. Global L-(+)-Ergothioneine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global L-(+)-Ergothioneine Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global L-(+)-Ergothioneine Revenue Market Share by Region (2021-2032) Figure 18. Global L-(+)-Ergothioneine Sales (2021-2032) & (kg) Figure 19. Global L-(+)-Ergothioneine Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 20. Global L-(+)-Ergothioneine Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico L-(+)-Ergothioneine Sales YoY (2021-2032) & (kg) Figure 22. Europe L-(+)-Ergothioneine Sales YoY (2021-2032) & (kg) Figure 23. China L-(+)-Ergothioneine Sales YoY (2021-2032) & (kg) Figure 24. Asia (Excluding China) L-(+)-Ergothioneine Sales YoY (2021-2032) & (kg) Figure 25. South America, Middle East and Africa L-(+)-Ergothioneine Sales YoY (2021-2032) & (kg) Figure 26. Global L-(+)-Ergothioneine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global L-(+)-Ergothioneine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global L-(+)-Ergothioneine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global L-(+)-Ergothioneine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global L-(+)-Ergothioneine Revenue Market Share by Type (2021-2032) Figure 32. Global L-(+)-Ergothioneine Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 33. Global L-(+)-Ergothioneine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global L-(+)-Ergothioneine Sales Market Share by Type (2021-2032) Figure 35. Global L-(+)-Ergothioneine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global L-(+)-Ergothioneine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global L-(+)-Ergothioneine Revenue Market Share by Application (2021-2032) Figure 38. Global L-(+)-Ergothioneine Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 39. Global L-(+)-Ergothioneine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global L-(+)-Ergothioneine Sales Market Share by Application (2021-2032) Figure 41. North America L-(+)-Ergothioneine Revenue Share by Type (2021-2032) Figure 42. North America L-(+)-Ergothioneine Sales Share by Type (2021-2032) Figure 43. North America L-(+)-Ergothioneine Revenue Share by Application (2021-2032) Figure 44. North America L-(+)-Ergothioneine Sales Share by Application (2021-2032) Figure 45. North America L-(+)-Ergothioneine Revenue Share by Country (2021-2032) Figure 46. North America L-(+)-Ergothioneine Sales Share by Country (2021-2032) Figure 47. Europe L-(+)-Ergothioneine Revenue Share by Type (2021-2032) Figure 48. Europe L-(+)-Ergothioneine Sales Share by Type (2021-2032) Figure 49. Europe L-(+)-Ergothioneine Revenue Share by Application (2021-2032) Figure 50. Europe L-(+)-Ergothioneine Sales Share by Application (2021-2032) Figure 51. Europe L-(+)-Ergothioneine Revenue Share by Country (2021-2032) Figure 52. Europe L-(+)-Ergothioneine Sales Share by Country (2021-2032) Figure 53. China L-(+)-Ergothioneine Revenue Share by Type (2021-2032) Figure 54. China L-(+)-Ergothioneine Sales Share by Type (2021-2032) Figure 55. China L-(+)-Ergothioneine Revenue Share by Application (2021-2032) Figure 56. China L-(+)-Ergothioneine Sales Share by Application (2021-2032) Figure 57. Asia L-(+)-Ergothioneine Revenue Share by Type (2021-2032) Figure 58. Asia L-(+)-Ergothioneine Sales Share by Type (2021-2032) Figure 59. Asia L-(+)-Ergothioneine Revenue Share by Application (2021-2032) Figure 60. Asia L-(+)-Ergothioneine Sales Share by Application (2021-2032) Figure 61. Asia L-(+)-Ergothioneine Revenue Share by Country (2021-2032) Figure 62. Asia L-(+)-Ergothioneine Sales Share by Country (2021-2032) Figure 63. SAMEA L-(+)-Ergothioneine Revenue Share by Type (2021-2032) Figure 64. SAMEA L-(+)-Ergothioneine Sales Share by Type (2021-2032) Figure 65. SAMEA L-(+)-Ergothioneine Revenue Share by Application (2021-2032) Figure 66. SAMEA L-(+)-Ergothioneine Sales Share by Application (2021-2032) Figure 67. SAMEA L-(+)-Ergothioneine Revenue Share by Country (2021-2032) Figure 68. SAMEA L-(+)-Ergothioneine Sales Share by Country (2021-2032) Figure 69. L-(+)-Ergothioneine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. L-(+)-Ergothioneine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Fermentation
  • Enzymatic Synthesis
  • Chemical Synthesis
Applications
  • Dietary Supplements
  • Food & Beverages
  • Cosmetics & Personal Care
  • Pet Nutrition
Companies covered
  • Bloomage Biotech
  • Chuanning Biotechnology
  • Shanghai EGT Synbio
  • GeneIII Biotechnology
  • Readline Biotech
  • SIYOMICRO
  • Abiochem
  • Magic Health
  • Seedling Bio
  • Focusfreda
  • Nutri Force
  • Natural Field
  • GsynBio
  • Hechen Bioworkx
  • Changzhou Kaixing Biotechnology
  • Spec Chem Industry
  • Conagen
  • Mironova Labs
  • NAGASE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 L-(+)-Ergothioneine Market by Type
  3. 1.2.1 Global L-(+)-Ergothioneine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fermentation
  5. 1.2.3 Enzymatic Synthesis
  6. 1.2.4 Chemical Synthesis
  7. 1.3 L-(+)-Ergothioneine Market by Application
  8. 1.3.1 Global L-(+)-Ergothioneine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Dietary Supplements
  10. 1.3.3 Food & Beverages
  11. 1.3.4 Cosmetics & Personal Care
  12. 1.3.5 Pet Nutrition
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 L-(+)-Ergothioneine Market Dynamics
  1. 2.1 L-(+)-Ergothioneine Industry Trends
  2. 2.2 L-(+)-Ergothioneine Industry Drivers
  3. 2.3 L-(+)-Ergothioneine Industry Opportunities and Challenges
  4. 2.4 L-(+)-Ergothioneine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global L-(+)-Ergothioneine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global L-(+)-Ergothioneine Revenue by Region
  3. 3.2.1 Global L-(+)-Ergothioneine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global L-(+)-Ergothioneine Revenue by Region (2021-2026)
  5. 3.2.3 Global L-(+)-Ergothioneine Revenue by Region (2027-2032)
  6. 3.2.4 Global L-(+)-Ergothioneine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global L-(+)-Ergothioneine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global L-(+)-Ergothioneine Sales by Region
  9. 3.4.1 Global L-(+)-Ergothioneine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global L-(+)-Ergothioneine Sales by Region (2021-2026)
  11. 3.4.3 Global L-(+)-Ergothioneine Sales by Region (2027-2032)
  12. 3.4.4 Global L-(+)-Ergothioneine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global L-(+)-Ergothioneine Revenue by Manufacturers
  2. 4.1.1 Global L-(+)-Ergothioneine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global L-(+)-Ergothioneine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global L-(+)-Ergothioneine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global L-(+)-Ergothioneine Sales by Manufacturers
  6. 4.2.1 Global L-(+)-Ergothioneine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global L-(+)-Ergothioneine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global L-(+)-Ergothioneine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global L-(+)-Ergothioneine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global L-(+)-Ergothioneine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global L-(+)-Ergothioneine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global L-(+)-Ergothioneine Manufacturers, Product Type & Application
  13. 4.7 Global L-(+)-Ergothioneine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global L-(+)-Ergothioneine Market CR5 and HHI
  16. 4.8.2 2025 L-(+)-Ergothioneine Tier 1, Tier 2, and Tier 3
5 L-(+)-Ergothioneine Market by Type
  1. 5.1 Global L-(+)-Ergothioneine Revenue by Type
  2. 5.1.1 Global L-(+)-Ergothioneine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global L-(+)-Ergothioneine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global L-(+)-Ergothioneine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global L-(+)-Ergothioneine Sales by Type
  6. 5.2.1 Global L-(+)-Ergothioneine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global L-(+)-Ergothioneine Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global L-(+)-Ergothioneine Sales Market Share by Type (2021-2032)
  9. 5.3 Global L-(+)-Ergothioneine Price by Type
6 L-(+)-Ergothioneine Market by Application
  1. 6.1 Global L-(+)-Ergothioneine Revenue by Application
  2. 6.1.1 Global L-(+)-Ergothioneine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global L-(+)-Ergothioneine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global L-(+)-Ergothioneine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global L-(+)-Ergothioneine Sales by Application
  6. 6.2.1 Global L-(+)-Ergothioneine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global L-(+)-Ergothioneine Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global L-(+)-Ergothioneine Sales Market Share by Application (2021-2032)
  9. 6.3 Global L-(+)-Ergothioneine Price by Application
7 Company Profiles
  1. 7.1 Bloomage Biotech
  2. 7.1.1 Bloomage Biotech Company Information
  3. 7.1.2 Bloomage Biotech Business Overview
  4. 7.1.3 Bloomage Biotech L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bloomage Biotech L-(+)-Ergothioneine Product Portfolio
  6. 7.1.5 Bloomage Biotech Recent Developments
  7. 7.2 Chuanning Biotechnology
  8. 7.2.1 Chuanning Biotechnology Company Information
  9. 7.2.2 Chuanning Biotechnology Business Overview
  10. 7.2.3 Chuanning Biotechnology L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chuanning Biotechnology L-(+)-Ergothioneine Product Portfolio
  12. 7.2.5 Chuanning Biotechnology Recent Developments
  13. 7.3 Shanghai EGT Synbio
  14. 7.3.1 Shanghai EGT Synbio Company Information
  15. 7.3.2 Shanghai EGT Synbio Business Overview
  16. 7.3.3 Shanghai EGT Synbio L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai EGT Synbio L-(+)-Ergothioneine Product Portfolio
  18. 7.3.5 Shanghai EGT Synbio Recent Developments
  19. 7.4 GeneIII Biotechnology
  20. 7.4.1 GeneIII Biotechnology Company Information
  21. 7.4.2 GeneIII Biotechnology Business Overview
  22. 7.4.3 GeneIII Biotechnology L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GeneIII Biotechnology L-(+)-Ergothioneine Product Portfolio
  24. 7.4.5 GeneIII Biotechnology Recent Developments
  25. 7.5 Readline Biotech
  26. 7.5.1 Readline Biotech Company Information
  27. 7.5.2 Readline Biotech Business Overview
  28. 7.5.3 Readline Biotech L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Readline Biotech L-(+)-Ergothioneine Product Portfolio
  30. 7.5.5 Readline Biotech Recent Developments
  31. 7.6 SIYOMICRO
  32. 7.6.1 SIYOMICRO Company Information
  33. 7.6.2 SIYOMICRO Business Overview
  34. 7.6.3 SIYOMICRO L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SIYOMICRO L-(+)-Ergothioneine Product Portfolio
  36. 7.6.5 SIYOMICRO Recent Developments
  37. 7.7 Abiochem
  38. 7.7.1 Abiochem Company Information
  39. 7.7.2 Abiochem Business Overview
  40. 7.7.3 Abiochem L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Abiochem L-(+)-Ergothioneine Product Portfolio
  42. 7.7.5 Abiochem Recent Developments
  43. 7.8 Magic Health
  44. 7.8.1 Magic Health Company Information
  45. 7.8.2 Magic Health Business Overview
  46. 7.8.3 Magic Health L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Magic Health L-(+)-Ergothioneine Product Portfolio
  48. 7.8.5 Magic Health Recent Developments
  49. 7.9 Seedling Bio
  50. 7.9.1 Seedling Bio Company Information
  51. 7.9.2 Seedling Bio Business Overview
  52. 7.9.3 Seedling Bio L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Seedling Bio L-(+)-Ergothioneine Product Portfolio
  54. 7.9.5 Seedling Bio Recent Developments
  55. 7.10 Focusfreda
  56. 7.10.1 Focusfreda Company Information
  57. 7.10.2 Focusfreda Business Overview
  58. 7.10.3 Focusfreda L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Focusfreda L-(+)-Ergothioneine Product Portfolio
  60. 7.10.5 Focusfreda Recent Developments
  61. 7.11 Nutri Force
  62. 7.11.1 Nutri Force Company Information
  63. 7.11.2 Nutri Force Business Overview
  64. 7.11.3 Nutri Force L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Nutri Force L-(+)-Ergothioneine Product Portfolio
  66. 7.11.5 Nutri Force Recent Developments
  67. 7.12 Natural Field
  68. 7.12.1 Natural Field Company Information
  69. 7.12.2 Natural Field Business Overview
  70. 7.12.3 Natural Field L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Natural Field L-(+)-Ergothioneine Product Portfolio
  72. 7.12.5 Natural Field Recent Developments
  73. 7.13 GsynBio
  74. 7.13.1 GsynBio Company Information
  75. 7.13.2 GsynBio Business Overview
  76. 7.13.3 GsynBio L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 GsynBio L-(+)-Ergothioneine Product Portfolio
  78. 7.13.5 GsynBio Recent Developments
  79. 7.14 Hechen Bioworkx
  80. 7.14.1 Hechen Bioworkx Company Information
  81. 7.14.2 Hechen Bioworkx Business Overview
  82. 7.14.3 Hechen Bioworkx L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hechen Bioworkx L-(+)-Ergothioneine Product Portfolio
  84. 7.14.5 Hechen Bioworkx Recent Developments
  85. 7.15 Changzhou Kaixing Biotechnology
  86. 7.15.1 Changzhou Kaixing Biotechnology Company Information
  87. 7.15.2 Changzhou Kaixing Biotechnology Business Overview
  88. 7.15.3 Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Product Portfolio
  90. 7.15.5 Changzhou Kaixing Biotechnology Recent Developments
  91. 7.16 Spec Chem Industry
  92. 7.16.1 Spec Chem Industry Company Information
  93. 7.16.2 Spec Chem Industry Business Overview
  94. 7.16.3 Spec Chem Industry L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Spec Chem Industry L-(+)-Ergothioneine Product Portfolio
  96. 7.16.5 Spec Chem Industry Recent Developments
  97. 7.17 Conagen
  98. 7.17.1 Conagen Company Information
  99. 7.17.2 Conagen Business Overview
  100. 7.17.3 Conagen L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Conagen L-(+)-Ergothioneine Product Portfolio
  102. 7.17.5 Conagen Recent Developments
  103. 7.18 Mironova Labs
  104. 7.18.1 Mironova Labs Company Information
  105. 7.18.2 Mironova Labs Business Overview
  106. 7.18.3 Mironova Labs L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Mironova Labs L-(+)-Ergothioneine Product Portfolio
  108. 7.18.5 Mironova Labs Recent Developments
  109. 7.19 NAGASE
  110. 7.19.1 NAGASE Company Information
  111. 7.19.2 NAGASE Business Overview
  112. 7.19.3 NAGASE L-(+)-Ergothioneine Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 NAGASE L-(+)-Ergothioneine Product Portfolio
  114. 7.19.5 NAGASE Recent Developments
8 North America
  1. 8.1 North America L-(+)-Ergothioneine Market Size by Type
  2. 8.1.1 North America L-(+)-Ergothioneine Revenue by Type (2021-2032)
  3. 8.1.2 North America L-(+)-Ergothioneine Sales by Type (2021-2032)
  4. 8.1.3 North America L-(+)-Ergothioneine Price by Type (2021-2032)
  5. 8.2 North America L-(+)-Ergothioneine Market Size by Application
  6. 8.2.1 North America L-(+)-Ergothioneine Revenue by Application (2021-2032)
  7. 8.2.2 North America L-(+)-Ergothioneine Sales by Application (2021-2032)
  8. 8.2.3 North America L-(+)-Ergothioneine Price by Application (2021-2032)
  9. 8.3 North America L-(+)-Ergothioneine Market Size by Country
  10. 8.3.1 North America L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America L-(+)-Ergothioneine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe L-(+)-Ergothioneine Market Size by Type
  2. 9.1.1 Europe L-(+)-Ergothioneine Revenue by Type (2021-2032)
  3. 9.1.2 Europe L-(+)-Ergothioneine Sales by Type (2021-2032)
  4. 9.1.3 Europe L-(+)-Ergothioneine Price by Type (2021-2032)
  5. 9.2 Europe L-(+)-Ergothioneine Market Size by Application
  6. 9.2.1 Europe L-(+)-Ergothioneine Revenue by Application (2021-2032)
  7. 9.2.2 Europe L-(+)-Ergothioneine Sales by Application (2021-2032)
  8. 9.2.3 Europe L-(+)-Ergothioneine Price by Application (2021-2032)
  9. 9.3 Europe L-(+)-Ergothioneine Market Size by Country
  10. 9.3.1 Europe L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe L-(+)-Ergothioneine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China L-(+)-Ergothioneine Market Size by Type
  2. 10.1.1 China L-(+)-Ergothioneine Revenue by Type (2021-2032)
  3. 10.1.2 China L-(+)-Ergothioneine Sales by Type (2021-2032)
  4. 10.1.3 China L-(+)-Ergothioneine Price by Type (2021-2032)
  5. 10.2 China L-(+)-Ergothioneine Market Size by Application
  6. 10.2.1 China L-(+)-Ergothioneine Revenue by Application (2021-2032)
  7. 10.2.2 China L-(+)-Ergothioneine Sales by Application (2021-2032)
  8. 10.2.3 China L-(+)-Ergothioneine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia L-(+)-Ergothioneine Market Size by Type
  2. 11.1.1 Asia L-(+)-Ergothioneine Revenue by Type (2021-2032)
  3. 11.1.2 Asia L-(+)-Ergothioneine Sales by Type (2021-2032)
  4. 11.1.3 Asia L-(+)-Ergothioneine Price by Type (2021-2032)
  5. 11.2 Asia L-(+)-Ergothioneine Market Size by Application
  6. 11.2.1 Asia L-(+)-Ergothioneine Revenue by Application (2021-2032)
  7. 11.2.2 Asia L-(+)-Ergothioneine Sales by Application (2021-2032)
  8. 11.2.3 Asia L-(+)-Ergothioneine Price by Application (2021-2032)
  9. 11.3 Asia L-(+)-Ergothioneine Market Size by Country
  10. 11.3.1 Asia L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia L-(+)-Ergothioneine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA L-(+)-Ergothioneine Market Size by Type
  2. 12.1.1 SAMEA L-(+)-Ergothioneine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA L-(+)-Ergothioneine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA L-(+)-Ergothioneine Price by Type (2021-2032)
  5. 12.2 SAMEA L-(+)-Ergothioneine Market Size by Application
  6. 12.2.1 SAMEA L-(+)-Ergothioneine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA L-(+)-Ergothioneine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA L-(+)-Ergothioneine Price by Application (2021-2032)
  9. 12.3 SAMEA L-(+)-Ergothioneine Market Size by Country
  10. 12.3.1 SAMEA L-(+)-Ergothioneine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA L-(+)-Ergothioneine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA L-(+)-Ergothioneine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 L-(+)-Ergothioneine Value Chain Analysis
  2. 13.1.1 L-(+)-Ergothioneine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 L-(+)-Ergothioneine Production Mode & Process
  6. 13.2 L-(+)-Ergothioneine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 L-(+)-Ergothioneine Distributors
  9. 13.2.3 L-(+)-Ergothioneine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst